The New Peptide Craze: Is Any of This Safe?
Dr. Mike of Renaissance Periodization goes through twelve peptides named in a planned federal review and ranks how strong the human evidence is for each.
With Dr. Mike
Key moments
Tap a moment to play the video from there.
- 0:00Panel to vet twelve peptidesDr. Mike explains the plan for an expert panel to review 12 peptides for possible fast-track approval and asks how excited viewers should be.
- 1:47BPC-157 evidence and limitsHe describes BPC-157 as a tissue repair candidate with moderate to large effects in preclinical studies, but says human data is not enough to judge safety.
- 2:58Thymosin beta-4 and TB-500He says the evidence is even thinner than for BPC-157 and raises a theoretical concern about new blood vessel formation feeding existing tumors.
- 6:29MOTS-c and dosing questionsHe covers the metabolic claims for MOTS-c and says he does not use it because he calculates the muscle benefits would need roughly a vial a week.
- 9:04Dihexa and cognition researchHe calls the preclinical data on dihexa strong but says there is essentially no human clinical evidence and raises cancer-relevance concerns.
- 10:43MK-677 and growth hormoneHe describes MK-677 as a growth hormone secretagogue with large IGF-1 effects, human evidence and a very strong appetite increase.
- 12:46Melanotan II benefits and side effectsHe lists tanning, libido and appetite effects, and side effects including nausea, priapism, darkened moles and, rarely, kidney toxicity.
- 16:26Semax and its Russian researchHe says Semax has been studied for stroke and cognition, but most evidence is preclinical or from older studies done in Russia.
- 18:35Ranking and overall takeHe sorts the twelve into three tiers by evidence strength and says none is a heavy-hitter for muscle growth.
What the video says
Dr. Mike of Renaissance Periodization opens with the news that RFK has pushed through a plan for an expert panel to vet 12 specific peptides for a possible fast track to regulatory approval. He calls this a good direction, since it could eventually mean legal access through a doctor's prescription instead of the gray market. The rest of the video is a quick pass through each peptide, covering what it is claimed to do, the downsides he names, and how strong the evidence is.
For most of the list, his main point is that the evidence is preclinical or very thin in humans. He describes BPC-157 and TB-500 as tissue repair candidates with moderate to large effects in preclinical studies but too little human data to judge safety. He says the same limits apply to Epitalon, GHK-Cu as an injectable, MOTS-c, KPV, DSIP and Semax. On dihexa and cathelicidin he raises theoretical concerns, such as growth pathways and inflammation that can go either way. He also mentions practical problems like unclear dosing for MOTS-c and the usual purity worries with gray market products.
He treats MK-677 and Melanotan II differently, saying both have real human evidence. He describes MK-677 as raising growth hormone and IGF-1 and increasing appetite sharply. He describes Melanotan II as affecting tanning, libido and appetite, with side effects he lists as nausea, flushing, headache, yawning, priapism, darkened moles and freckles, and rarely kidney toxicity.
In his closing ranking, he puts MK-677 and Melanotan II in the group with real human pharmacology and real trade-offs. BPC-157, cathelicidin, MOTS-c, KPV and dihexa fall in a plausible but under-researched group. Epitalon, Semax, DSIP and TB-500 are in the group where the evidence is too small to say much. His overall view is that none of the twelve is revolutionary for muscle growth, and that he is more interested in drugs in the pharmaceutical pipeline. The video also includes jokes and a plug for the channel's apps.
On each compound
BPC-1571:47
Dr. Mike says BPC-157 shows moderate to large tissue repair effects in preclinical studies, but human trial evidence is too limited to say how well it works or how safe it is. He places it in his middle tier.
See how your DNA reads BPC-157TB-5002:58
Dr. Mike describes TB-500 and related fragments as similar to BPC-157 in some effects but with even thinner evidence, mostly preclinical and cell work. He mentions theoretical concerns about angiogenesis and immune effects.
See how your DNA reads TB-500Epithalon4:06
Dr. Mike says Epitalon is popular in longevity circles for claimed effects on telomere length and aging biomarkers. He says the support comes mainly from cell and preclinical studies and older human studies, with little known about downsides.
See how your DNA reads EpithalonGHK-Cu5:21
Dr. Mike says GHK-Cu has decent support as a topical skin and wound molecule, with small to moderate effects. He says little is known about injecting it.
See how your DNA reads GHK-CuMOTS-c6:29
Dr. Mike describes MOTS-c as a mitochondrial peptide with claimed metabolic and exercise-like effects, mostly preclinical. He says dosing is unclear and that he does not use it.
See how your DNA reads MOTS-cDSIP7:52
Dr. Mike says DSIP, which he also calls emideltide, was discovered in the 1970s and is linked to sleep, with older and scattered evidence. He names possible sedation, paradoxical sleep disruption, mood changes and endocrine effects as downsides.
See how your DNA reads DSIPDihexa9:04
Dr. Mike says dihexa looks strong in preclinical work on synapse formation and cognition but has essentially no human evidence. He raises theoretical cancer relevance because it triggers cell growth pathways.
See how your DNA reads DihexaMelanotan II12:46
Dr. Mike says Melanotan II has a large effect size with human evidence, affecting pigmentation, libido and appetite. He lists nausea, flushing, headache, yawning, priapism, permanent darkening of moles and freckles, and rare kidney toxicity.
See how your DNA reads Melanotan IIKPV15:37
Dr. Mike describes KPV as a tripeptide studied for anti-inflammatory, gut, skin and antimicrobial effects. He says human safety and efficacy are minimally characterized and delivery and stability are practical issues.
See how your DNA reads KPVSemax16:26
Dr. Mike says Semax was developed mainly in Russia and studied for stroke, cognition and stress resilience. He says long-term safety data are very limited and much of the human work is old.
See how your DNA reads Semax“none of them are truly revolutionary”
What this video doesn’t settle
- The video relies on one presenter's quick summary of each peptide and does not cite specific studies, so the evidence claims cannot be checked from it.
- It does not establish safe or effective doses for any of the twelve peptides, and Dr. Mike says MOTS-c dosing in particular is unclear.
- Most of the effect sizes quoted come from preclinical or cell studies, so they do not show how the peptides perform in people.
Questions this video answers
Which peptides does Dr. Mike say have the strongest human evidence?
He names MK-677 and Melanotan II as the two with real human pharmacology evidence and trade-offs he says are reasonably well understood. He places the rest of the twelve in groups with plausible but under-researched effects or evidence too small to judge.
What does Dr. Mike say about BPC-157 safety?
He says BPC-157 looks strong for tissue repair in preclinical studies, but there is not enough high-level human evidence to know its downsides. He also mentions the usual gray market concerns about purity and dosing.
What side effects of Melanotan II does Dr. Mike mention?
He lists nausea, flushing, headache and yawning, plus appetite loss and priapism. He also says it can permanently darken moles and freckles and, in rare serious cases, cause kidney toxicity.
What is the government review of twelve peptides that Dr. Mike describes?
He says RFK pushed through a plan for an expert panel to vet 12 specific peptides for a possible fast track to regulatory approval. He says that could eventually allow legal access by prescription for some of them.
Does Dr. Mike think these peptides build muscle?
He says none of the twelve is a heavy-hitter for muscle growth. He says MK-677 can support muscle gain only when androgens, sleep, training and diet are all in place.
Video by Renaissance Periodization on YouTube, embedded as published. The summary is written by PeptidesDNA from the video; every claim in it is the speaker’s. Not affiliated with or endorsed by the creator. Not medical advice.
